12th December 2019
MEDTRAC is pleased to announce that ADLIFE foundation has subject to agreement offered to provide research funding for its low-cost DNA based health screening platform.

MEDTRAC is a startup company based in UK, Ireland & Sweden bringing an advanced diagnostics platform to market.

Subject to the approval of the board, ADLIFE will provide funding to MEDTRAC to carry out a proof of concept, support field trials in Sweden, obtain a medical product license and operate as a licensed lab in multiple jurisdictions.

The ADLIFE Foundation is a Swedish charitable foundation that attracts donations from corporations and the public to support research.

Clas Dahlen, the founder of ADLIFE Foundation engaged prominent members of the medical establishment in Sweden to support the foundation’s charitable work.